NCT06178406

Brief Summary

Observational prospective study with an analysis of the changes in brain structure and related functional connectivity in women with dysmenorrhea.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 21, 2023

Completed
11 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

December 21, 2023

Status Verified

December 1, 2023

Enrollment Period

8 months

First QC Date

September 4, 2023

Last Update Submit

December 19, 2023

Conditions

Keywords

dysmenorrhea, magnetic resonance imaging

Outcome Measures

Primary Outcomes (1)

  • The functional connectivity of functional magnetic resonance imaging

    Functional magnetic resonance imaging (fMRI)-based functional connectivity (FC) commonly characterizes the functional connections in the brain.

    1 month

Secondary Outcomes (1)

  • Grey Matter volume

    1 month

Study Arms (2)

dysmenorrhea

Behavioral: dysmenorrhea

female healthy controls

Interventions

dysmenorrheaBEHAVIORAL

Dysmenorrhea, defined as painful menstrual cramps of uterine origin, is the most common gynecological condition among women of reproductive age.

dysmenorrhea

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All the patients with dysmenorrhea underwent pelvic ultrasonography to identify the cause of dysmenorrhea. The study will be conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Women's Hospital School of Medicine Zhejiang University. All participants will give their written informed consent.

You may qualify if:

  • Right-handedness, as confirmed by the Edinburgh Handedness Inventory
  • A regular menstrual cycle of approximately 21 to 35 days
  • A history of menstrual pain longer than 6 months
  • Not taking any medication or using other methods to treat dysmenorrhea in the past month
  • Score of \>= 40mm on the VAS (visual analogue scale) in recent three menstrual cycles

You may not qualify if:

  • Any psychiatric or neurological disorders, particularly premenstrual dysphoric disorder
  • Using oral contraceptives, hormonal supplements, or any central-acting medication (eg, opioid, antiepileptics) within 6 months before the study
  • Having a metal or pacemaker implant, claustrophobia, or any contraindications to MR
  • Head injury with loss of consciousness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dysmenorrhea

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2023

First Posted

December 21, 2023

Study Start

January 1, 2024

Primary Completion

August 31, 2024

Study Completion

December 31, 2024

Last Updated

December 21, 2023

Record last verified: 2023-12